Grzegorz Sienski, PhDAstraZeneca における Director and Project Leaderスピーカー
アジェンダセッション
Therapeutic Genome Editing with ePsCas9 Using Lipid Nanoparticles
, 5:00pmセッションを見る
This site is part of the Informa Connect Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Therapeutic Genome Editing with ePsCas9 Using Lipid Nanoparticles